CRISPR-Cas3 Innovation Holds Promise for Disease Cures
Cornell University | Apr 12, 2019
The system can efficiently erase long stretches of DNA from a targeted site in the human genome
gene editing
Researchers Optimize Gene Editing for Sickle-Cell Disease and Beta Thalassemia
Boston Children's Hospital | Mar 29, 2019
New strategy for editing blood stem cells is more efficient and targeted